ASSESSMENT OF THE PHARMACOKINETICS OF CO-ADMINISTERED METFORMIN AND LOBEGLITAZONE, A NOVEL THIAZOLIDINEDIONE ANTIHYPERGLYCEMIC AGENT, IN HEALTHY VOLUNTEERS

被引：0
|
作者：
Shin, D. [1 ]
Kim, T. [1 ]
Jeon, H. [1 ]
Yoon, S. [1 ]
Cho, J. [1 ]
Yu, K. [1 ]
Shin, S. [1 ]
Jang, I. [1 ]
机构：
[1] Seoul Natl Univ, Coll Med, Seoul, South Korea
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2011年 / 89卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：S90 / S90
页数：1
相关论文
共 50 条
  • [21] Pharmacokinetics of Oral and Intravenous Paracetamol (Acetaminophen) When Co-Administered with Intravenous Morphine in Healthy Adult Subjects
    Raffa, Robert B.
    Pawasauskas, Jayne
    Pergolizzi, Joseph V., Jr.
    Lu, Luke
    Chen, Yin
    Wu, Sutan
    Jarrett, Brant
    Fain, Randi
    Hill, Lawrence
    Devarakonda, Krishna
    CLINICAL DRUG INVESTIGATION, 2018, 38 (03) : 259 - 268
  • [22] Pharmacokinetics of Oral and Intravenous Paracetamol (Acetaminophen) When Co-Administered with Intravenous Morphine in Healthy Adult Subjects
    Robert B. Raffa
    Jayne Pawasauskas
    Joseph V. Pergolizzi
    Luke Lu
    Yin Chen
    Sutan Wu
    Brant Jarrett
    Randi Fain
    Lawrence Hill
    Krishna Devarakonda
    Clinical Drug Investigation, 2018, 38 : 259 - 268
  • [23] Population pharmacokinetics and exposure–response assessment of veliparib co-administered with temozolomide in patients with myeloid leukemias
    Renu Singh
    Shailly Mehrotra
    Mathangi Gopalakrishnan
    Ivana Gojo
    Judith E. Karp
    Jacqueline M. Greer
    Alice Chen
    Richard Piekarz
    Brian F. Kiesel
    Jogarao Gobburu
    Michelle A. Rudek
    Jan H. Beumer
    Cancer Chemotherapy and Pharmacology, 2019, 83 : 319 - 328
  • [24] SINGLE AND MULTIPLE DOSE PHARMACOKINETICS OF A NOVEL ANTIINFLAMMATORY AGENT IN HEALTHY-VOLUNTEERS
    ADAIR, SF
    LUDERS, RC
    GIEDRAITIS, L
    BRUNNER, L
    WAGNER, WE
    JOURNAL OF PHARMACEUTICAL SCIENCES, 1987, 76 (11) : S61 - S61
  • [25] Safety, pharmacokinetics and pharmacodynamics of remogliflozin etabonate, a novel SGLT2 inhibitor, and metformin when co-administered in subjects with type 2 diabetes mellitus
    Elizabeth K Hussey
    Anita Kapur
    Robin O’Connor-Semmes
    Wenli Tao
    Bryan Rafferty
    Joseph W Polli
    Charles D James
    Robert L Dobbins
    BMC Pharmacology and Toxicology, 14
  • [26] Safety, pharmacokinetics and pharmacodynamics of remogliflozin etabonate, a novel SGLT2 inhibitor, and metformin when co-administered in subjects with type 2 diabetes mellitus
    Hussey, Elizabeth K.
    Kapur, Anita
    O'Connor-Semmes, Robin
    Tao, Wenli
    Rafferty, Bryan
    Polli, Joseph W.
    James, Charles D., Jr.
    Dobbins, Robert L.
    BMC PHARMACOLOGY & TOXICOLOGY, 2013, 14
  • [27] Population pharmacokinetics and exposure-response assessment of veliparib co-administered with temozolomide in patients with myeloid leukemias
    Singh, Renu
    Mehrotra, Shailly
    Gopalakrishnan, Mathangi
    Gojo, Ivana
    Karp, Judith E.
    Greer, Jacqueline M.
    Chen, Alice
    Piekarz, Richard
    Kiesel, Brian F.
    Gobburu, Jogarao
    Rudek, Michelle A.
    Beumer, Jan H.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2019, 83 (02) : 319 - 328
  • [28] Comparable Lumefantrine Oral Bioavailability when Co-administered With Oil-Fortified Maize Porridge or Milk in Healthy Volunteers
    Mwebaza, Norah
    Jerling, Markus
    Gustafsson, Lars L.
    Obua, Celestino
    Waako, Paul
    Mahindi, Margarita
    Ntale, Muhammad
    Beck, Olof
    Hellgren, Urban
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2013, 113 (01) : 66 - 72
  • [29] Tolerability and pharmacokinetics of metformin and the dipeptidyl peptidase-4 inhibitor sitagliptin when co-administered in patients with type 2 diabetes
    Herman, Gary A.
    Bergman, Arthur
    Yi, Bingming
    Kipnes, Mark
    CURRENT MEDICAL RESEARCH AND OPINION, 2006, 22 (10) : 1939 - 1947
  • [30] No effect of the novel antidiabetic agent nateglinide on the pharmacokinetics and anticoagulant properties of warfarin in healthy volunteers
    Anderson, DM
    Shelley, S
    Crick, N
    Buraglio, M
    JOURNAL OF CLINICAL PHARMACOLOGY, 2002, 42 (12): : 1358 - 1365
12345